A5078155280- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Cardiac Valve Diseases and Treatments
- Heart Failure Treatment and Management
- Venous Thromboembolism Diagnosis and Management
- Congenital Heart Disease Studies
- Cardiac and Coronary Surgery Techniques
- Aortic Disease and Treatment Approaches
- Cardiac, Anesthesia and Surgical Outcomes
- Infective Endocarditis Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
- Transplantation: Methods and Outcomes
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Issues in Pregnancy
- Acute Ischemic Stroke Management
- Central Venous Catheters and Hemodialysis
- Cardiac tumors and thrombi
- Fuel Cells and Related Materials
- Long-Term Effects of COVID-19
- Traumatic Brain Injury and Neurovascular Disturbances
- Trauma Management and Diagnosis
- Heparin-Induced Thrombocytopenia and Thrombosis
University of Rochester
2018-2025
Cardiovascular Research Center
2025
University of Rochester Medical Center
2018-2024
Newark Beth Israel Medical Center
2024
Medical University of Vienna
2021
Leiden University Medical Center
2021
Osaka University
2020
Strong Memorial Hospital
2019
Brigham and Women's Hospital
2012-2017
Memorial Medical Center
2016
Little is known about the temporal trends and outcomes for extra-corporeal membrane oxygenation (ECMO) in patients with high-risk pulmonary embolism (PE) United States. We queried National Inpatient Sample (NIS) database from 2005 to 2013 identify admitted PE. Our objective was determine ECMO use also assessed in-hospital among PE receiving ECMO. evaluated 77,809 hospitalizations There an upward trend utilization of 0.07% 1.1% ( p = 0.015). utilized more urban teaching hospitals large...
Minimally invasive aortic valve surgery (mini AVR) is a safe and effective treatment option at many hospital centers, but there has not been widespread adoption of the procedure. Critics mini AVR have called for additional evidence with direct comparison to replacement (AVR) via full sternotomy (FS).Our approach through hemi-sternotomy (HS). We performed propensity-score matched analysis all patients undergoing isolated FS or HS our institution since 2002, resulting in 552 pairs. Baseline...
Background This study investigates the use of modern machine learning (ML) techniques to improve prediction survival after orthotopic heart transplantation (OHT). Methods Retrospective adult patients undergoing primary, isolated OHT between 2000 and 2019 as identified in United Network for Organ Sharing (UNOS) registry. The primary outcome was 1-year post-transplant survival. Patients were randomly divided into training (80%) validation (20%) sets. Dimensionality reduction data re-sampling...
Objectives The HeartMate 3 (HM3) left ventricular assist device (LVAD) provides substantial improvement in long-term morbidity and mortality advanced heart failure patients. SWIFT study compares thoracotomy-based implantation clinical outcomes with standard median sternotomy. Methods We conducted a prospective, multicenter, single-arm patients eligible for HM3 surgical technique (bilateral thoracotomy or partial upper sternotomy thoracotomy). composite primary endpoint was survival free of...
As questions remain about the risk–benefit of left ventricular assist device (LVAD) therapy, we evaluated association between LVAD versus medical therapy for competing risk all-cause mortality and readmission. Among consecutive patients advanced heart failure (HF) 260 were referred implantation 292 continued in this retrospective, observational database study. At 2 years, was significantly higher among medically managed recipients (37% vs. 25%, p = 0.014). Separation event rates appeared...
The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical outcome, and higher mortality for who experience significant ventricular tachyarrhythmia (VTA). We hypothesize that novel prophylactic intra-operative VTA ablation protocol at time implantation may reduce recurrent adverse events postimplant.We...
The COVID-19 pandemic caused significant disruptions in surgical care. Whether these disproportionately impacted economically disadvantaged individuals is unknown.